Skip to main content
. Author manuscript; available in PMC: 2021 Jun 10.
Published in final edited form as: N Engl J Med. 2021 Jun 10;384(23):2177–2186. doi: 10.1056/NEJMoa2030243

Figure 4: Intention-to-treat efficacy.

Figure 4:

Shown is the protective efficacy (expressed as 100×(1−OR)) of wMel-infected Aedes aegypti deployments against virologically-confirmed dengue of any serotype (All VCDs), by infecting DENV serotype, and against hospitalised VCD. VCDs with ‘Unknown serotype’ were test-negative by DENV RT-PCR and test-positive for DENV NS1 antigen. Seven participants had two DENV serotypes detected during the same febrile episode: four with serotypes 1 and 2, two with serotypes 1 and 4, and one with serotypes 2 and 4.